METROPOLIS

Metropolis Healthcare Share Price

 

 

Invest in Metropolis Healthcare with 3.37X leverage

Invest with MTF

Performance

  • Low
  • ₹1,946
  • High
  • ₹1,980
  • 52 Week Low
  • ₹1,315
  • 52 Week High
  • ₹2,263
  • Open Price₹1,975
  • Previous Close₹1,975
  • Volume92,308

Investment Returns

  • Over 1 Month -1.48%
  • Over 3 Month -6.09%
  • Over 6 Month + 14.78%
  • Over 1 Year -9.61%

Smart Investing Starts Here Start SIP with Metropolis Healthcare for Steady Growth!

Invest Now

Metropolis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 64.4
  • PEG Ratio
  • 9.3
  • Market Cap Cr
  • 10,185
  • P/B Ratio
  • 8.6
  • Average True Range
  • 52.83
  • EPS
  • 30.53
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -16.46
  • RSI
  • 47.33
  • MFI
  • 81.15

Metropolis Healthcare Financials

Metropolis Healthcare Technicals

EMA & SMA

Current Price
₹1,965.40
-9.3 (-0.47%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹1,973.53
  • 50 Day
  • ₹1,994.43
  • 100 Day
  • ₹1,969.98
  • 200 Day
  • ₹1,927.29

Resistance and Support

1963.67 Pivot Speed
  • R3 2,016.13
  • R2 1,998.07
  • R1 1,981.73
  • S1 1,947.33
  • S2 1,929.27
  • S3 1,912.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Metropolis Healthcare Ltd. is a leading diagnostic service provider in India, offering a wide range of pathology tests and healthcare solutions. With an extensive network of labs and collection centers, it serves patients across India and international markets.

Metropolis Healthcare has an operating revenue of Rs. 1,483.31 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 14% is healthy, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 6% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 51 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Metropolis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-04 Quarterly Results & Interim Dividend
2025-08-07 Quarterly Results
2025-05-13 Audited Results
2025-02-04 Quarterly Results
2024-12-09 Preferential issue of shares Inter-alia to consider : 1. Issuance of equity shares of the Company on a preferential basis, in accordance with the applicable laws, subject to the approval of shareholders of the Company. per share(400%)Interim Dividend
Date Purpose Remarks
2025-11-11 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend
View Metropolis Healthcare Dividend History Arrow

Metropolis Healthcare F&O

Metropolis Healthcare Shareholding Pattern

48.89%
30.69%
2.21%
12.52%
3.69%
2%

Metropolis Healthcare FAQs

Metropolis Healthcare share price is ₹1,965 As on 13 November, 2025 | 23:09

The Market Cap of Metropolis Healthcare is ₹10185.1 Cr As on 13 November, 2025 | 23:09

The P/E ratio of Metropolis Healthcare is 64.4 As on 13 November, 2025 | 23:09

The PB ratio of Metropolis Healthcare is 8.6 As on 13 November, 2025 | 23:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23